Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg)
Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) is a medicine authorised by Swissmedic under authorisation number 68472. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 December 2021 and the authorisation is valid without a time limit. ATC code N04BA02 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 68472 |
|---|---|
| Name | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) |
| Full name | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg), Tabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N04BA02 |
| First authorisation | 01 December 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg), Tabletten | B | 01 December 2021 |
| 2 | Levodopa / Benserazid Devatis 125 mg (100 mg + 25 mg), Tabletten | B | 01 December 2021 |
| 3 | Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten | B | 01 December 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 2 | 100 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 3 | 30 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 4 | 100 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 5 | 30 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 6 | 100 | Tablette(n) | N04BA02 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) authorised in Switzerland?
Yes. Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) is authorised by Swissmedic under authorisation number 68472, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) have?
Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg)?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.